Contact this trialFirst, we need to learn more about you.
SMARCA2 Degrader
PRT7732 for Solid Tumors
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new drug called PRT7732 in patients with specific types of advanced or metastatic solid tumors. The main goal is to see if the drug is safe and well-toler
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service